Major Depressive Disorder (MDD) is a clinically heterogeneous syndrome with diverse etiological pathways. Traditional Epigenome-Wide Association Studies (EWAS) have successfully identified risk loci based on differential methylation magnitude. As a complementary perspective, effect-size-based ranking alone may not fully capture regulatory nodes that exhibit modest methylation changes but occupy critical upstream positions in biological networks. Here, we report findings and hypotheses from a two-tier computational analysis of DNA methylation data (GSE198904; \(n=206\) ), combining conventional statistical approaches with machine learning-assisted regulatory inference.